DT
Talabot Frischknecht-Ayer, Dominique
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors | Cell communication and signaling |  | 2025 | 96 | 44 | ||
| Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice | Frontiers in immunology | | 2024 | 138 | 47 | ||
| Oxidation-sensitive cysteines drive IL-38 amyloid formation | Cell reports | | 2024 | 126 | 37 | ||
| IL ‐38 orchestrates proliferation and differentiation in human keratinocytes | Experimental dermatology | | 2022 | 268 | 190 | ||
| Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytes | Gene | | 2022 | 283 | 164 | ||
| Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes | PLOS ONE | | 2019 | 381 | 205 | ||
| The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression | PLOS ONE | | 2018 | 514 | 271 | ||
| Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses | Journal of Immunology |  | 2017 | 760 | 2 | ||
| Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice | The Journal of immunology | | 2015 | 678 | 2 | ||
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | 2014 | 675 | 0 | ||
| Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis | Joint bone spine | | 2012 | 750 | 796 | ||
| The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology |  | 2012 | 712 | 0 | ||
| Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | | 2012 | 674 | 0 | ||
| IL-36R ligands are potent regulators of dendritic and T cells | Blood | | 2011 | 660 | 0 | ||
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | 2009 | 658 | 0 | ||
| Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | | 2009 | 682 | 512 | ||
| The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 | Cytokine | | 2008 | 713 | 0 | ||
| Expression and function of junctional adhesion molecule-C in human and experimental arthritis | Arthritis research & therapy | | 2007 | 648 | 341 | ||
| Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | Cytokine | | 2007 | 524 | 0 | ||
| Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | Arthritis research & therapy | | 2004 | 486 | 173 |
